Neurological analysis of respiratory, cardiovascular and neuromuscular effects of brevetoxin in cats
- PMID: 2992123
- DOI: 10.1016/0041-0101(85)90036-4
Neurological analysis of respiratory, cardiovascular and neuromuscular effects of brevetoxin in cats
Abstract
Effects of brevetoxin were evaluated in cats anesthetized with pentobarbital under conditions of controlled end-expiratory pCO2 and constant body temperature. Recordings were made of arterial blood pressure, heart rate, respiratory pattern, diaphragm EMG, evoked tibialis muscle twitch and evoked contraction of the nictitating membrane. Electrical stimulation was employed for periodic excitation of the medullary respiratory center, the phrenic nerve, the peroneal nerve and the cervical sympathetic nerve. Brevetoxin was prepared at a concentration of 1.0 mg/ml in an aqueous medium of 2.5% ethanol plus 2.5% Emulphor 620 (General Aniline and Film Corp., New York). Small i.v. bolus injections of the toxin (40 micrograms/kg) evoked, without tachyphylaxis, the Bezold-Jarisch reflex triad of bradycardia, hypotension and bradypnea. This effect was essentially abolished by vagotomy. Continued injections then resulted in pressor reactions and tachycardia, along with the development of respiratory dysrhythmia. Large doses of brevetoxin (160 micrograms/kg i.v.) caused somatomotor seizures accompanied by severe hypertension, that occurred even after decerebration and cervical spinal cord transection. Cranial intra-arterial and intra-cerebroventricular injections of brevetoxin produced hypertension and respiratory depression more effectively than did i.v. injections. Systemic cumulation of the toxin, with the respiration supported artificially, caused death from cardiovascular collapse, without significant blockade of neuromuscular and ganglionic transmission. It is concluded that brevetoxin exerts its major toxic effects on the circulation and respiration through reflex and central actions, largely sparing peripheral motor mechanisms.
Similar articles
-
Central respiratory and circulatory effects of Gymnodinium breve toxin in anaesthetized cats.Br J Pharmacol. 1980 Oct;70(2):249-56. doi: 10.1111/j.1476-5381.1980.tb07930.x. Br J Pharmacol. 1980. PMID: 7191740 Free PMC article.
-
Cardiovascular effects of brevetoxins in dogs.Toxicon. 1985;23(3):505-15. doi: 10.1016/0041-0101(85)90035-2. Toxicon. 1985. PMID: 4040670
-
General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.Arzneimittelforschung. 1990 Jul;40(7):735-46. Arzneimittelforschung. 1990. PMID: 1977393
-
Cardiovascular actions of 2,5-dimethoxy-4-methylamphetamine (DOM) in the cat.Eur J Pharmacol. 1975 Apr;31(2):305-12. doi: 10.1016/0014-2999(75)90053-9. Eur J Pharmacol. 1975. PMID: 1056857
-
Effect of brevetoxin-B on the neuromuscular transmission of the mouse diaphragm.J Formos Med Assoc. 1991 May;90(5):431-6. J Formos Med Assoc. 1991. PMID: 1680978
Cited by
-
Properties and use of botulinum toxin and other microbial neurotoxins in medicine.Microbiol Rev. 1992 Mar;56(1):80-99. doi: 10.1128/mr.56.1.80-99.1992. Microbiol Rev. 1992. PMID: 1579114 Free PMC article. Review.
-
Literature Review of Florida Red Tide: Implications for Human Health Effects.Harmful Algae. 2004 Apr 1;3(2):99-115. doi: 10.1016/j.hal.2003.08.005. Harmful Algae. 2004. PMID: 20411030 Free PMC article.
-
The type B brevetoxin (PbTx-3) adversely affects development, cardiovascular function, and survival in Medaka (Oryzias latipes) embryos.Environ Health Perspect. 2003 Dec;111(16):1920-5. doi: 10.1289/ehp.6386. Environ Health Perspect. 2003. PMID: 14644667 Free PMC article.
-
Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.J Nat Prod. 2010 Apr 23;73(4):536-40. doi: 10.1021/np900541w. J Nat Prod. 2010. PMID: 20218657 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous